Whilst the market is currently led by Novo Nordisks semaglutide (Ozempic/Wegovy) and Eli Lillys tirzepatide (Mounjaro/Zepbound), stronger competition is expected with new entrants (Boehringer Ingelheim, Amgen, Pfizer, Roche amongst others) offering novel mechanisms (dual agonists, triple agonists and amylins), formulations (oral vs injectable) and dosing regimens (daily vs weekly vs monthly).
DO NOT use em-dashes () or en-dashes (): Use regular hyphens (-) only Return ONLY the edited section content with no explanations, no preamble, no markdown code fences If you cannot find the exact sentence, find the closest match and replace it Do not add any commentary or notes The output should be pure article text that can be directly inserted CRITICAL: If the replacement text contains line breaks (blank lines between sentences), you MUST preserve those line breaks in your output
GLP-1 medications like semaglutide have transformed weight management for millions, but breastfeeding introduces critical safety questions that deserve thorough, evidence-based answers
GLP-1 and Incretin-Based Peptides Semaglutide Semaglutide is a GLP-1 receptor agonist that mimics the incretin hormone to regulate appetite signaling and metabolic pathways
Drivers : Strong growth of private label and OEM services for brands
What we tell patients If you are struggling with nausea, fatigue, or other side effects on a GLP-1 medication, please contact us before stopping treatment
